EBM Analytics, Crows Nest, Australia.
Joint Orthopaedic Centre, Sydney, Australia.
J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(2):2309499020926790. doi: 10.1177/2309499020926790.
This study reports the results of a multimodal thromboprophylaxis protocol for lower limb arthroplasty involving risk stratification, intraoperative calf compression, aspirin prophylaxis and early (within 4 h) post-operative mobilisation facilitated by the use of local infiltration analgesia. The study also aimed to identify risk factors for venous thromboembolism (VTE) within a 3-month period following surgery for patients deemed not at elevated risk.
Patients undergoing knee/hip arthroplasty or hip resurfacing were preoperatively screened for VTE risk factors, and those at standard risk were placed on a thromboprophylaxis protocol consisting of intraoperative intermittent calf compression during surgery, 300 mg/day aspirin for 6 weeks from surgery and early mobilisation. Patients were screened bilaterally for deep vein thrombosis (DVT) on post-operative days 10-14. If proximal DVT was detected, patients were anticoagulated and outcomes were recorded. Symptomatic VTE within 3 months of surgery were recorded separately. Patient notes were retrospectively collated and cross-validated against ultrasound reports.
At initial screening, the rate of proximal DVT was 0.54% (1.1% for knee and 0.27% for hip), and distal DVT was 6.63% (20.11% for knee and 2.31% for hip). One small, nonfatal pulmonary embolism (PE) was detected within 3 months of surgery (0.28% of total knee arthroplasty patients or 0.07% of total). All proximal DVTs were treated successfully with anticoagulants; however, one patient suffered a minor PE approximately 10 months post-operatively. Regression analysis identified knee implant and advanced age as independent risk factors for VTE in this cohort.
Although knee arthroplasty patients remained at higher risk than hip replacement/resurfacing patients, the incidence and outcomes of VTE remained positive compared with protocols involving extended immobilisation, and episodes of PE were extremely rare. Thus, we conclude that patients at standard preoperative risk of VTE may safely be taken through the post-operative recovery process with a combination of intraoperative mechanical prophylaxis, early mobilisation and post-operative aspirin, with closer attention required for older patients and those undergoing knee surgery.
本研究报告了一种多模式下肢关节置换术血栓预防方案的结果,该方案涉及风险分层、术中小腿压缩、阿司匹林预防以及局部浸润性镇痛辅助下的早期(术后 4 小时内)术后活动。该研究还旨在确定在术后 3 个月内,对于被认为没有高风险的患者,手术相关静脉血栓栓塞症(VTE)的危险因素。
在膝关节/髋关节置换术或髋关节表面置换术前,对 VTE 危险因素进行筛查,对于标准风险患者,采用包括手术中间歇性小腿压缩、术后 6 周每天 300 毫克阿司匹林和早期活动的血栓预防方案。术后第 10-14 天,对双侧患者进行深静脉血栓(DVT)筛查。如果发现近端 DVT,则对患者进行抗凝治疗,并记录结果。术后 3 个月内出现症状性 VTE 分别记录。回顾性收集患者病历并与超声报告交叉验证。
在初始筛查时,近端 DVT 的发生率为 0.54%(膝关节为 1.1%,髋关节为 0.27%),远端 DVT 的发生率为 6.63%(膝关节为 20.11%,髋关节为 2.31%)。术后 3 个月内发现 1 例小的非致命性肺栓塞(PE)(膝关节全关节置换术患者的发生率为 0.28%,全髋关节置换术患者的发生率为 0.07%)。所有近端 DVT 均通过抗凝治疗成功治疗;然而,1 例患者在术后约 10 个月时发生小的 PE。回归分析确定膝关节植入物和高龄是该队列中 VTE 的独立危险因素。
尽管膝关节置换术患者的风险仍高于髋关节置换术/表面置换术患者,但与涉及长期固定的方案相比,VTE 的发生率和结果仍然是积极的,并且 PE 发作极为罕见。因此,我们得出结论,对于术前 VTE 风险标准的患者,可以安全地通过术中机械预防、早期活动和术后阿司匹林相结合的方式进行术后恢复过程,对于老年患者和膝关节手术患者需要更加密切关注。